Scientists to study effectiveness of AstraZeneca vaccine as a nasal spray

Thirty healthy Oxford-based volunteers aged 18-40 will receive the vaccine through an intranasal spray device (Yui Mok/PA)
Thirty healthy Oxford-based volunteers aged 18-40 will receive the vaccine through an intranasal spray device (Yui Mok/PA)